FDA Recall Open, Classified

CD11b APC: ASR, REF: 340936, and CE, REF: 333143

Recall: Z-0641-2024 · Initiated October 25, 2023

Recall

Recall Number
Z-0641-2024
Event Number
93569
Firm
Becton, Dickinson and Company, BD Biosciences
FEI Number
2916837
Product Code
MVU
Status
Open, Classified
Root Cause
Nonconforming Material/Component
Initiated
October 25, 2023
Posted
January 5, 2024
Address
2350 Qume Dr, San Jose, CA, 95131-1812

Description

CD11b APC: ASR, REF: 340936, and CE, REF: 333143

Reason

In vitro diagnostics product that impacts the quality of cell staining can cause low or dim fluorescence signal, which can lead to potential false negative results and misdiagnosis of hematological malignancy, delayed treatment, and the need for additional patient samples.

Action

On 10/25/2023, correction notices were mailed and emailed to customers who were asked to do the following: 1) Discard all products subject to the recall following your institution s process for destruction. 2) Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 3) If lot 3114730 was used, review results and take appropriate action as deemed necessary. 4) Complete and return the response form via email, [email protected] or via Link, https://bdx.my.site.com/CC360/s/impactedproducts?rn=BDB-23-4854 Customers who require further assistance can contact the firm's North American Regional Complaint Center via phone, 1-844-823-5433, say "recall" when prompted Mon-Fri 8:00am and 5:00pm CT, or via email, [email protected]

Distribution

Worldwide - US Nationwide distribution including in the states of IL, MN, FL, MI, MD, NC, NY, CA, GA, AR, KS, PA, NH, TX, OK, MA, MO, DC, AZ, IN, NJ, TN, WA, VA, CT and the countries of CA, BE, SG, HK, TW, BR, MY, IN, BO, PE, JP, MX, CL, KR, UY, AU.

Quantity

464 Vials